Skye Bioscience, Inc. Quarterly Common Stock, Shares, Issued from Q3 2012 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Skye Bioscience, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2012 to Q2 2024.
  • Skye Bioscience, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 28.1M shares, a 97.1% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 28.1M -943M -97.1% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 28.1M -943M -97.1% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 12.3M +8.7M +238% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 12.3M -484M -97.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 972M +476M +95.9% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 972M +476M +95.9% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 3.65M -472M -99.2% Dec 31, 2022 10-K 2024-03-22
Q3 2022 496M +19.8M +4.16% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 496M +99.8M +25.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 496M +128M +34.9% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 476M +188M +65.3% Dec 31, 2021 10-K 2023-03-31
Q3 2021 476M +226M +90.4% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 396M +213M +116% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 368M +184M +101% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 288M +105M +57.5% Dec 31, 2020 10-K 2022-03-28
Q3 2020 250M +116M +86.5% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 183M +49.1M +36.6% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 183M +49.3M +36.8% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 183M +49M +36.6% Dec 31, 2019 10-K 2021-03-02
Q3 2019 134M +650K +0.49% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 134M +1.39M +1.05% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 134M +1.49M +1.13% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 134M +100M +298% Dec 31, 2018 10-K 2020-03-23
Q3 2018 133M +103M +335% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 133M +102M +337% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 132M +105M +385% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 33.6M +12.1M +55.9% Dec 31, 2017 10-K 2019-03-14
Q3 2017 30.7M +10.8M +54% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 30.3M +10.4M +52.3% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 27.3M +7.4M +37.1% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 21.6M +1.66M +8.34% Dec 31, 2016 10-K 2018-03-19
Q3 2016 19.9M +1.84M +10.2% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 19.9M +3.65M +22.4% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 19.9M +3.65M +22.4% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 19.9M +3.9M +24.4% Dec 31, 2015 10-K 2017-03-10
Q3 2015 18.1M +6.31M +53.6% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 16.3M +12.6M +349% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 16.3M +12.6M +349% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 16M +8.23M +106% Dec 31, 2014 10-K 2016-03-21
Q3 2014 11.8M +8.15M +225% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 3.62M +476K +15.1% Jul 31, 2014 10-Q 2014-09-15
Q1 2014 3.62M +476K +15.1% Apr 30, 2014 10-Q 2014-06-05
Q4 2013 7.77M Dec 31, 2013 10-K 2015-03-27
Q3 2013 3.62M +1.1M +43.4% Oct 31, 2013 10-Q 2014-09-15
Q2 2013 3.15M Jul 31, 2013 10-Q 2013-09-16
Q1 2013 3.15M Apr 30, 2013 10-Q 2013-06-27
Q3 2012 2.53M Oct 31, 2012 10-K 2014-01-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.